Minimally Invasive Sacroiliac Joint Fusion Compared with Sham Operation (SIFSO Trial)
Journal of Bone and Joint Surgery · 2026
DOI: 10.2106/jbjs.25.00918 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Bone and Joint Surgery, 2026. Verfasst von Thomas Johan Kibsgård und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Orthopaedic Surgery, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Sacroiliac Joint, Spinal Fusion, Low Back Pain, Arthrodesis. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Minimally invasive fusion of the sacroiliac joint (SIJ) as a treatment for SIJ pain remains controversial. The SIFSO trial was a double-blinded, sham-controlled randomized trial with a primary end point of 6 months. Sixty-three patients were randomized to undergo either minimally invasive SIJ fusion or sham surgery. At the 6-month primary end point, a mean reduction of 2.6 points on the Numeric Rating Scale (NRS) was demonstrated in the surgical group, compared with a reduction of 1.7 points in the sham group (group difference: −1.0 point [95% confidence interval (CI), −2.2 to 0.3; p = 0.13]). Patients in the sham group were allowed to cross over to surgery after unblinding at 6 months. The current report describes the 2-year outcomes of all patients, including those who underwent SIJ fusion as part of the initial surgical group, those who crossed over to fusion after sham surgery, and those who remained in the sham group. After unblinding at 6 months, 26 of the 31 patients in the sham group crossed over to fusion. All 63 patients completed the 2-year follow-up. The mean age at baseline was 45 years (range, 26 to 63 years), and 59 of the 63 patients were female. Compared with baseline, the reduction in the NRS score at 2 years was 3.1 (95% CI, 2.0 to 4.1) in the initial fusion group (n = 32), 1.6 (95% CI, −1.8 to 5.0) in the sham group that did not cross over (n = 5), and 3.5 (95% CI, 2.5 to 4.5) in the crossover group (n = 26). In conclusion, surgically treated patients experienced significant pain reduction and improved physical function at the 2-year follow-up, compared with baseline, and the results of SIJ fusion were sustained from 6 months to 2 years. Due to crossover and unblinding, it was not possible to determine the actual effect of minimally invasive SIJ fusion compared with sham surgery at 2 years. Level of Evidence: Therapeutic Level II . See Instructions for Authors for a complete description of levels of evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Orthopaedic Surgery, Oslo University Hospital, Oslo, Norway.
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
- Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.
- Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
- Department of Orthopaedics and Hand Surgery, Uppsala University Hospital, Uppsala, Sweden.
- Department of Reconstructive Orthopedics, Karolinska University Hospital, Stockholm, Sweden.
ORCID-Profile: Thomas Johan Kibsgård, Paul Gerdhem, Elias Diarbakerli, Engelke Marie Randers
Zitieren
APA
Kibsgård, T. J., Gerdhem, P., Diarbakerli, E., & Randers, E. M. (2026). Minimally Invasive Sacroiliac Joint Fusion Compared with Sham Operation (SIFSO Trial). Journal of Bone and Joint Surgery. https://doi.org/10.2106/jbjs.25.00918
Vancouver
Kibsgård TJ, Gerdhem P, Diarbakerli E, Randers EM. Minimally Invasive Sacroiliac Joint Fusion Compared with Sham Operation (SIFSO Trial). Journal of Bone and Joint Surgery. 2026. doi:10.2106/jbjs.25.00918
BibTeX
@article{Kibsgrd2026,
author = {Kibsgård, Thomas Johan and Gerdhem, Paul and Diarbakerli, Elias and Randers, Engelke Marie},
title = {Minimally Invasive Sacroiliac Joint Fusion Compared with Sham Operation (SIFSO Trial)},
journal = {Journal of Bone and Joint Surgery},
year = {2026},
doi = {10.2106/jbjs.25.00918}
}
EUVIMED